Cargando…

Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine

BACKGROUND: The essentially unlimited expansion potential and the pluripotency of human embryonic stem cells (hESCs) make them attractive for cell-based therapeutic purposes. Although hESCs can indefinitely proliferate in culture, unlike transformed cancer cells, they are endowed with a cell-intrins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Videla-Richardson, Guillermo A., Furmento, Verónica A., Garcia, Carolina P., Morris-Hanon, Olivia, Sevlever, Gustavo E., Romorini, Leonardo, Scassa, María E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712821/ https://www.ncbi.nlm.nih.gov/pubmed/31462218 http://dx.doi.org/10.1186/s12860-019-0222-3

Ejemplares similares

The Cell Cycle Inhibitors p21(Cip1) and p27(Kip1) Control Proliferation but Enhance DNA Damage Resistance of Glioma Stem Cells
por: Morris-Hanon, Olivia, et al.
Publicado: (2017)

Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
por: Romorini, Leonardo, et al.
Publicado: (2013)

Chemical hypoxia induces apoptosis of human pluripotent stem cells by a NOXA-mediated HIF-1α and HIF-2α independent mechanism
por: Isaja, Luciana, et al.
Publicado: (2020)

Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells
por: Vera, Mariana Belén, et al.
Publicado: (2022)

Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199
por: García, Carolina Paola, et al.
Publicado: (2016)

AKT/GSK3β signaling pathway is critically involved in human pluripotent stem cell survival
por: Romorini, Leonardo, et al.
Publicado: (2016)

Acute severe hypoxia induces apoptosis of human pluripotent stem cells by a HIF-1α and P53 independent mechanism
por: Mucci, Sofía, et al.
Publicado: (2022)

Protocol for morphometric analysis of neurons derived from human pluripotent stem cells
por: Mucci, Sofía, et al.
Publicado: (2022)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice
por: Rabhi, Nabil, et al.
Publicado: (2021)

Identification of the miRNAome of early mesoderm progenitor cells and cardiomyocytes derived from human pluripotent stem cells
por: Garate, Ximena, et al.
Publicado: (2018)

Several Human Cyclin-Dependent Kinase Inhibitors, Structurally Related to Roscovitine, As New Anti-Malarial Agents
por: Houzé, Sandrine, et al.
Publicado: (2014)

A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement
por: Luzzani, Carlos, et al.
Publicado: (2015)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair
por: Federico, Mario, et al.
Publicado: (2010)

Selective antitumor activity of roscovitine in head and neck cancer
por: Gary, Cyril, et al.
Publicado: (2016)

Cyclin-dependent kinase inhibitor r-roscovitine reduces lipoteichoic acid lung inflammation and improves the resolution of antibiotic-treated Streptococcus pneumoniae pneumonia
por: Hoogendijk, AJ, et al.
Publicado: (2009)

Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling
por: Quaglino, Ana, et al.
Publicado: (2007)

The molecular determinants of R-roscovitine block of hERG channels
por: Cernuda, Bryan, et al.
Publicado: (2019)

Roscovitine ameliorates endotoxin-induced uveitis through neutrophil apoptosis
por: Jiang, Zhao-Xin, et al.
Publicado: (2016)

Roscovitine, a Cyclin-Dependent Kinase-5 Inhibitor, Decreases Phosphorylated Tau Formation and Death of Retinal Ganglion Cells of Rats after Optic Nerve Crush
por: Hirokawa, Takahisa, et al.
Publicado: (2021)

Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

The Cdk5 inhibitor Roscovitine increases LTP induction in corticostriatal synapses
por: Miranda-Barrientos, Jorge, et al.
Publicado: (2014)

Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation
por: Xie, Tiancheng, et al.
Publicado: (2017)

Effect of roscovitine on developmental competence of small follicle-derived buffalo oocytes
por: Pandey, Sriti, et al.
Publicado: (2018)

How to Spell and Pronounce Aluminium
por: Driscoll, W. E.
Publicado: (1871)

The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells
por: Kretzschmar, Christin, et al.
Publicado: (2014)

Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
por: Nair, Binoj C, et al.
Publicado: (2011)

Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells
por: Cui, Chunying, et al.
Publicado: (2013)

Correction: Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy
por: Tejero, Rocio, et al.
Publicado: (2020)

Pronouncing Medical Lexicon
Publicado: (1856)

Mesenchymal Stromal Cells Isolated from Ectopic but Not Eutopic Endometrium Display Pronounced Immunomodulatory Activity In Vitro
por: Lupatov, Alexey Yu., et al.
Publicado: (2021)

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
por: Benson, C, et al.
Publicado: (2007)

Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents
por: Montanaro, Gabriele, et al.
Publicado: (2013)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Enhancement of Peripheral Nerve Regrowth by the Purine Nucleoside Analog and Cell Cycle Inhibitor, Roscovitine
por: Law, Vincent, et al.
Publicado: (2016)

The NPH-II Helicase Displays Efficient DNA·RNA Helicase Activity and a Pronounced Purine Sequence Bias
por: Taylor, Sean David, et al.
Publicado: (2010)

MicroRNA characterization in equine induced pluripotent stem cells
por: Moro, Lucia Natalia, et al.
Publicado: (2018)

Special Schools: An International Pronouncement
Publicado: (1936)

Cannot write session to /tmp/vufind_sessions/sess_slislenq3gkmclqd455aa87qlf